Panin (Italy) starts two new clinical trial in Europe


PANIN, an Italian-based pharmaceutical company, announces the starting of two new clinical trials in East Europe handled by Opera CRO. The tested products are vaginal suppositories for vaginal dryness and a spry formulation for earwax impaction. For both projects the first patient enrolled is planned in the second quarter of 2023. The clinical operations will be concluded in about one year.


Panin S.r.l. a socio unico was founded twenty years ago by the paediatrician Dr. Giorgio Panin. The aim of the company is to develop medical devices based on tocopherol acetate (vitamin E) and characterized by specific formulations. All these innovative formulations are patented and distributed in several European countries.

For more information: Tel: +39 0425 471323

About Opera CRO

Opera CRO is a contract research organization with over 25 years of experience in clinical research for drugs, medical devices, and food supplements. Headquartered in Romania and with local offices in Eastern and Western European countries, Opera CRO has successfully supported hundreds of companies to develop new products. Opera is the subsidiary of TIGERMED, the leading CRO in China, and acts as a bridge between its European clients and the Chinese market.